|
|
News for Healthier Living
Study Finds No Statistical Link Between Use of Semaglutide and Other GLP-1 Drugs and Risk of Degenerative Eye Disease in Adults with Type 2 Diabetes
An estimated 27% of U.S. adults with diabetes are using glucagon-like peptide-1 receptor agonists (GLP-1 RAs) -- a type of medication that mimics the GLP-1 hormone -- to lower blood sugar and support weight loss. Some research has suggested that their use can reduce the risk of developing other diseases.
July 17, 2026
July 24 2026July 23 2026July 22 2026July 21 2026July 20 2026July 17 2026July 16 2026July 15 2026July 14 2026July 13 2026July 12 2026
|
|
|
|
|